27^th Hellenic Conference of Clinical Oncology

1 Rabih Halabi, Trastuzumab induced sarcoidosis mimicking metastatic carcinoma, CHEST 2011; 140:56A. HalabiRabih Trastuzumab induced sarcoidosis mimicking metastatic carcinoma CHEST 2011 140 56A Search in Google Scholar

2 Dmitriy Cogan, A case of trastuzumab induced Pulmonary Sarcoidosis, CHEST, https://doi.org/10.1378/chest.1386625 CoganDmitriy A case of trastuzumab induced Pulmonary Sarcoidosis CHEST https://doi.org/10.1378/chest.1386625 Search in Google Scholar

3 P.T. Nigo, A case of trastuzumab induced sarcoidosis, American Society International Conference abstracts, 2017 NigoP.T. A case of trastuzumab induced sarcoidosis American Society International Conference abstracts 2017 Search in Google Scholar

1 Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Bass RB, Terry WJ, Igel TC, Kidd DD. Prostate cancer detection in a clonical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990; 143: 1146. CoonerWH MosleyBR RutherfordCL BeardJH PondHS BassRB TerryWJ IgelTC KiddDD Prostate cancer detection in a clonical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 1990 143 1146 Search in Google Scholar

2 Stamey TA, Kabalin JN. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 1989; 141: 1070. StameyTA KabalinJN Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients J Urol 1989 141 1070 Search in Google Scholar

3 Yamamoto S, Ito T, Akiyama A, Aizawa T, Miki M, Tachibana M. M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/ml. Int J Urol 2001; 8: 374. YamamotoS ItoT AkiyamaA AizawaT MikiM TachibanaM M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/ml Int J Urol 2001 8 374 Search in Google Scholar

4 Gkonos PJ, Krongrad A, Roos BA. Neuroendocrine peptides in the prostate. Urol Res 1995; 23: 81. GkonosPJ KrongradA RoosBA Neuroendocrine peptides in the prostate Urol Res 1995 23 81 Search in Google Scholar

5 Kimura N, Hoshi S, Takahashi M et al. Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors. J Urol 1997; 157: 565. KimuraN HoshiS TakahashiM Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors J Urol 1997 157 565 Search in Google Scholar

6 Aparicio A.M. Harzstark A.L. Corn P.G. et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013; 19: 3621–3630 AparicioA.M. HarzstarkA.L. CornP.G. Platinum-based chemotherapy for variant castrate-resistant prostate cancer Clin Cancer Res 2013 19 3621 3630 Search in Google Scholar